Acura Pharmaceuticals, Inc.
Palatine, US · New York corporation · 2 known investors
Biotech
Founders & leadership
AW
Albert W. BrzeczkoExecutive Officer
GK
George K. RossDirector
JF
James F. EmighExecutive Officer
BW
Bruce WessonDirector
IT
Immanuel ThangarajDirector
PA
Peter A. ClemensExecutive Officer
RB
Robert B. JonesExecutive Officer, Director
RS
Robert SeiserExecutive Officer
WS
William SkellyDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$4MraisedJul 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$4MraisedJul 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Albert W. BrzeczkoExecutive Officer
- George K. RossDirector
- James F. EmighExecutive Officer
- Bruce WessonDirector
- Immanuel ThangarajDirector
- Peter A. ClemensExecutive Officer
- Robert B. JonesExecutive Officer, Director
- Robert SeiserExecutive Officer
- William SkellyDirector
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Jul 2017
- Incorporated
- Corporation, New York
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.